|
⚲
|
| Keyboard |
| Richard Ghalie | |
|---|---|
| Firm | |
| Address | c/o Viracta Therapeutics, Inc 2533 S Coast Highway 101, Suite 210 Cardiff, CA 92007 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Viracta Subsidiary Inc | 021-391789 | Director | 65.0 M of 65.0 M |
||
| Viracta Therapeutics Inc | 021-382883 | Director | 40.0 M of 40.0 M |
||
| Viracta Therapeutics Inc | 021-352658 | Director | 16.8 M of 25.0 M |
||
| Viracta Therapeutics Inc | 021-332690 | Director | 5.7 M of 5.7 M |
||
| Viracta Therapeutics Inc | 021-327918 | Director | 10.7 M of 10.7 M |
||
| Viracta Therapeutics Inc | 021-315909 | Director | 2.7 M of 8.5 M |
||
| Viracta Therapeutics Inc | 021-284113 | Director | 9.9 M of 26.9 M |
||
| Hemaquest Pharmaceuticals Inc | 021-176133 | Executive Officer | 6.5 M of 16.0 M |
||